We added the following clinical trials to Metastatic Trial Search for December 2022. To see all clinical trials, please visit Metastatic Trial Search.
Stage IV HR-Positive Breast Cancer
- ARV-471 Hormone Therapy with Targeted Therapy for Advanced ER+, HER2- Breast Cancer
- OP-1250 Hormone Therapy with Targeted Therapy for Advanced HR+, HER2- Breast Cancer
- Evexomostat, Hormone Therapy, and Targeted Therapy for Women with Advanced HR+, HER- Breast Cancer with a PIK3CA Mutation and High Blood Sugar
Stage IV HER2-Positive Breast Cancer
- ORM-5029 Antibody Drug Conjugate for HER2 Positive or HER2 Low Breast Cancer
- Targeted Therapy for Metastatic HER2+ Breast Cancer with a PIK3CA Mutation
- ZN-A-1041 Targeted Therapy for Advanced HER2 Positive or HER2 Low Breast Cancer
Stage IV Triple-Negative Breast Cancer
- Bemarituzumab Targeted Therapy for Advanced Triple Negative Breast Cancer that Expresses FGFR2b
- Evexomostat and Chemotherapy for People with Advanced Triple Negative Breast Cancer and High Blood Sugar or High BMI
- BAY3375968 Immunotherapy with PD-1 Inhibitor for Advanced Triple Negative Breast Cancer
- ZEN-3694 Targeted Therapy with Chemotherapy and Immunotherapy for Advanced Triple Negative Breast Cancer that is PD-L1 Negative
- SGN-PDL1V Antibody Drug Conjugate for Advanced Triple Negative Breast Cancer
Other Stage IV Trials
- Gratitude Journaling and Goal Setting for Black Women with Breast Cancer and Breast Cancer Survivors
- Milademetan Targeted Therapy for Advanced Breast Cancer With TP53 and MDM2 Gene Amplification
- Improving Quality of Life and Cognitive Function After Radiation Therapy for People with Brain Metastases
- MRI Scans to Improve Brain Surgery for People with Brain Metastases
Last Modified on December 1, 2022
